UL Solutions CapEx increased by 19.0% to $69.00M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 35.3%, from $51.00M to $69.00M. Over 3 years (FY 2022 to FY 2025), CapEx shows an upward trend with a 6.3% CAGR.
An increase often signals growth initiatives and capacity expansion, while a decrease may suggest cost-cutting or a shift toward asset-light strategies.
This metric measures the cash outflows used to acquire, upgrade, and maintain physical assets such as property, building...
Commonly compared as a percentage of revenue; capital-intensive firms like Abbott require consistent investment to remain competitive in medical technology.
capital_expenditures| Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $41.00M | $41.00M | $41.00M | $41.00M | $63.00M | $50.00M | $43.00M | $59.00M | $57.00M | $56.00M | $66.00M | $58.00M | $51.00M | $42.00M | $46.00M | $58.00M | $69.00M |
| QoQ Change | — | +0.0% | +0.0% | +0.0% | +53.7% | -20.6% | -14.0% | +37.2% | -3.4% | -1.8% | +17.9% | -12.1% | -12.1% | -17.6% | +9.5% | +26.1% | +19.0% |
| YoY Change | — | — | — | — | +53.7% | +22.0% | +4.9% | +43.9% | -9.5% | +12.0% | +53.5% | -1.7% | -10.5% | -25.0% | -30.3% | +0.0% | +35.3% |